Always respectful and encouraging to all.
Professor Lisa Stamp is a professor in the Department of Medicine at the University of Otago, Christchurch, and an academic rheumatologist affiliated with the University and Te Whatu Ora Waitaha Canterbury. Her academic background includes an MB ChB from the University of Otago, a PhD from the University of Adelaide on allopurinol hypersensitivity, FRACP, DipMus from the University of Auckland, and election as a Fellow of the Royal Society Te Apārangi in 2023. Following her PhD, she returned to Christchurch in mid-2004, establishing a research programme, and she directs the Arthritis Research Theme there. She also holds clinical appointments as a rheumatologist.
Professor Stamp's research interests encompass gout and rheumatic diseases, with specializations in urate-lowering therapy, allopurinol dose escalation for target serum urate achievement, colchicine prophylaxis efficacy and safety, drug interactions, and treatment individualization. Key publications include the randomised controlled UpToDate trial on allopurinol dose escalation (Annals of the Rheumatic Diseases, 2017), co-authorship of Gout (Oxford Rheumatology Library, 2015), Gout in renal transplant recipients (2006), Cost-effectiveness of low dose colchicine prophylaxis when starting allopurinol (Arthritis Care & Research, 2025), and Easing the way to achieving target serum urate in people with gout (2024). She has garnered major awards such as the Medicines New Zealand Value of Medicines Award (2017) for influencing international gout guidelines, Arthritis New Zealand Jubilee Celebration Research Award (2016), University of Otago Christchurch Gold Medal for Research, and Rowheath Trust Award with Carl Smith Medal (2011). Her work has significantly impacted gout management practices.
